{"transactions":[{"id":247432,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Stock Appreciation Right","published_at":"2007-05-31T01:29:13.000Z","date":"2007-05-28","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock appreciation rights vest at a rate of 25% annually on May 28 from the years 2008 through 2011."}],"balance_after":150000,"derivative":{"exercise_price":54.41,"expiration_date":"2017-05-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001181431-07-036393","document":"rrd160889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107036393/rrd160889.xml","form_type":"4"}},{"id":247431,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Stock Appreciation Right","published_at":"2007-05-31T01:29:13.000Z","date":"2007-05-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest 100% on May 28, 2013."}],"balance_after":25000,"derivative":{"exercise_price":54.41,"exercise_date":"2013-05-28","expiration_date":"2017-05-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001181431-07-036393","document":"rrd160889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107036393/rrd160889.xml","form_type":"4"}},{"id":249965,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Common Stock","published_at":"2007-04-20T01:20:42.000Z","date":"2006-03-30","kind":"gift","acquired":false,"shares":46,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14113,"source":{"system":"sec-edgar","filing":"0001181431-07-026256","document":"rrd155051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107026256/rrd155051.xml","form_type":"5"}},{"id":249964,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Common Stock","published_at":"2007-04-20T01:20:42.000Z","date":"2006-03-01","kind":"gift","acquired":false,"shares":170,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14113,"source":{"system":"sec-edgar","filing":"0001181431-07-026256","document":"rrd155051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107026256/rrd155051.xml","form_type":"5"}},{"id":250725,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":65000,"derivative":{"exercise_price":59,"expiration_date":"2015-10-31","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250724,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":57.89,"expiration_date":"2015-10-31","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250723,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":75000,"derivative":{"exercise_price":48.355,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250722,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person has also entered into an agreement, effective as of December 22, 2006, with the Company to increase the exercise prices of the options specified above (which vested in 2005 or later and are potentially subject to a surtax under Section 409A of the Internal Revenue Code) to the closing price of the Company's common stock on the accounting measurement date for each option grant.  The accounting measurement date for each option grant was finalized on March 6, 2007. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":47.34,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250721,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":25000,"derivative":{"exercise_price":51.8139,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250720,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":75000,"derivative":{"exercise_price":47.34,"expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250719,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":138000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":138000,"derivative":{"exercise_price":44.3239,"expiration_date":"2014-12-07","underlying":"Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250718,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":138000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":138000,"derivative":{"exercise_price":39.85,"expiration_date":"2014-12-07","underlying":"Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250717,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":75000,"derivative":{"exercise_price":31.4239,"expiration_date":"2013-11-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250716,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":25000,"derivative":{"exercise_price":26.95,"expiration_date":"2013-11-28","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250715,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":200000,"derivative":{"exercise_price":24.5339,"expiration_date":"2013-02-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250714,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":0,"derivative":{"exercise_price":20.06,"expiration_date":"2013-02-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250713,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":140000,"derivative":{"exercise_price":21.7,"expiration_date":"2012-08-05","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250712,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":300000,"derivative":{"exercise_price":18.6375,"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250711,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":240000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":240000,"derivative":{"exercise_price":14.8,"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250710,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":120000,"derivative":{"exercise_price":13.3281,"expiration_date":"2010-07-26","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":250709,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Pub & Sr Mkt Grp"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-03-09T01:07:06.000Z","date":"2007-03-06","kind":"grant","acquired":true,"shares":26800,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"date","element":"transactionDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Statement of Changes in Beneficial Ownership on Form 4 (\"Form 4\") amends that certain Form 4 filed by the reporting person with the Securities and Exchange Commission (\"SEC\") on November 9, 2006 to reflect the amended exercise prices of the options specified above.  The options were repriced pursuant to an option repricing agreement the reporting person entered into with UnitedHealth Group Incorporated (the \"Company\") to (a) increase the exercise prices of each option with stated grant dates between 1994 and 2002 (each a \"Subject Option\") to the closing price of the Company's common stock on the accounting measurement date for the option grant, and (b) increase the exercise prices of certain post-2002 vested options held by the reporting person to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.  (continued in footnote no 2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The accounting measurement date for each option grant was finalized on March 6, 2007 when the Company filed with the SEC its annual report on Form 10-K for the year ended December 31, 2006 and restated its prior-year financial statements.  See the Form 4 filed by the reporting person with the SEC on November 9, 2006 for additional information."}],"balance_after":26800,"derivative":{"exercise_price":10.4297,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001181431-07-018063","document":"rrd150630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143107018063/rrd150630.xml","form_type":"4/A","original_submission_date":"2006-11-09"}},{"id":255425,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":140000,"derivative":{"expiration_date":"2012-08-05","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255424,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":20.535,"expiration_date":"2012-08-05","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255423,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":300000,"derivative":{"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255422,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":17.3875,"expiration_date":"2012-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255421,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":240000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":240000,"derivative":{"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255420,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":240000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":13.1719,"expiration_date":"2011-01-17","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255419,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":120000,"derivative":{"expiration_date":"2010-07-26","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255418,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":9.7735,"expiration_date":"2010-07-26","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255417,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":26800,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":26800,"derivative":{"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255416,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":26800,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":5.9532,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255415,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"grant","acquired":true,"shares":56000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":56000,"derivative":{"expiration_date":"2008-02-06","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":255414,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO,Ovations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2006-11-10T02:03:02.000Z","date":"2006-11-07","kind":"disposition_to_issuer","acquired":false,"shares":56000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person has entered into an agreement, dated November 7, 2006 (the \"Agreement\"), with UnitedHealth Group Incorporated (the \"Company\") to have the exercise prices of each option with recorded grant dates between 1994 and 2002 (each, a \"Subject Option\") reset to the closing price of the Company's common stock on the applicable accounting measurement date for the grant.  If any such closing price is less than the exercise price of the related option, no adjustment will be made.  These accounting measurement dates are being determined by the Company (the date of the determination, the \"Determination Date\").  In addition, the exercise prices of certain post-2002 vested options held by the reporting person will also be increased to account for the value attributable to the differences between such closing prices and the exercise prices of the previously exercised Subject Options.(Continued in Footnote2)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person has not listed these post-2002 options in this Form 4 as the list will not be finalized until the Company determines the applicable measurement dates for the Subject Options.  Within two business days after the Determination Date, the reporting person will file an amendment to this Form 4 to reflect the amended exercise prices of all relevant stock options.  See the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2006 for additional information. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options.  The other terms of the outstanding options (including the vesting of the options) remain unchanged."}],"balance_after":0,"derivative":{"exercise_price":6.5313,"expiration_date":"2008-02-06","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001181431-06-062885","document":"rrd135941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000118143106062885/rrd135941.xml","form_type":"4"}},{"id":263393,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Stock Appreciation Rights","published_at":"2006-05-04T23:17:48.000Z","date":"2006-05-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":150000,"derivative":{"exercise_price":48.58,"exercise_date":"2007-05-02","expiration_date":"2016-05-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000731766-06-000055","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176606000055/edgardoc.xml","form_type":"4"}},{"id":269822,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-12-30T21:36:49.000Z","date":"2005-12-27","kind":"gift","acquired":false,"shares":1087,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13915,"source":{"system":"sec-edgar","filing":"0000731766-05-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000141/edgardoc.xml","form_type":"4"}},{"id":269821,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-12-30T21:36:49.000Z","date":"2005-12-23","kind":"gift","acquired":false,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15002,"source":{"system":"sec-edgar","filing":"0000731766-05-000141","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000141/edgardoc.xml","form_type":"4"}},{"id":269940,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-12-22T21:21:54.000Z","date":"2005-12-08","kind":"gift","acquired":false,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15082,"source":{"system":"sec-edgar","filing":"0000731766-05-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000140/edgardoc.xml","form_type":"4"}},{"id":269939,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-12-22T21:21:54.000Z","date":"2005-12-07","kind":"gift","acquired":false,"shares":2483,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17335,"source":{"system":"sec-edgar","filing":"0000731766-05-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000140/edgardoc.xml","form_type":"4"}},{"id":272335,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-11-02T23:25:22.000Z","date":"2005-10-31","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65000,"derivative":{"exercise_price":57.89,"exercise_date":"2006-10-31","expiration_date":"2015-10-31","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000731766-05-000132","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000132/edgardoc.xml","form_type":"4"}},{"id":273744,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-10-18T20:06:44.000Z","date":"2005-10-18","kind":"gift","acquired":false,"shares":1783,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19818,"source":{"system":"sec-edgar","filing":"0000731766-05-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000121/edgardoc.xml","form_type":"4"}},{"id":276252,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-08-09T18:05:51.000Z","date":"2005-08-08","kind":"exercise","acquired":false,"shares":173200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in three equal annual installments beginning March 1, 2001."}],"balance_after":26800,"derivative":{"exercise_price":5.9532,"expiration_date":"2010-03-08","underlying":"Common Stock","underlying_shares":173200},"source":{"system":"sec-edgar","filing":"0000731766-05-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000105/edgardoc.xml","form_type":"4"}},{"id":276251,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-08-09T18:05:51.000Z","date":"2005-08-08","kind":"sale","acquired":false,"shares":173200,"price":51.1825,"value":8864809.0,"ownership":{"direct":true},"balance_after":21601,"source":{"system":"sec-edgar","filing":"0000731766-05-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000105/edgardoc.xml","form_type":"4"}},{"id":276250,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2005-08-09T18:05:51.000Z","date":"2005-08-08","kind":"exercise","acquired":true,"shares":173200,"price":5.9532,"value":1031094.24,"ownership":{"direct":true},"balance_after":194801,"source":{"system":"sec-edgar","filing":"0000731766-05-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000105/edgardoc.xml","form_type":"4"}},{"id":279492,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-05-04T21:25:31.000Z","date":"2005-05-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning May 2, 2006."}],"balance_after":50000,"derivative":{"exercise_price":94.68,"exercise_date":"2006-05-02","expiration_date":"2015-05-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-05-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176605000073/edgardoc.xml","form_type":"4"}},{"id":284075,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2004-12-09T21:52:19.000Z","date":"2004-12-07","kind":"grant","acquired":true,"shares":138000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 12/7/05."}],"balance_after":138000,"derivative":{"exercise_price":79.7,"expiration_date":"2014-12-07","underlying":"Common Stock","underlying_shares":138000},"source":{"system":"sec-edgar","filing":"0000731766-04-000201","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176604000201/edgardoc.xml","form_type":"4"}},{"id":297164,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-12-30T15:54:54.000Z","date":"2003-12-29","kind":"gift","acquired":false,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10095,"source":{"system":"sec-edgar","filing":"0000731766-03-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000035/edgardoc.xml","form_type":"4"}},{"id":297276,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-12-22T16:51:28.000Z","date":"2003-12-19","kind":"other","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Because this is the disposition of a derivative security, sale price does not apply."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Performance-based grant vested on annual review of performance guidelines."}],"balance_after":0,"derivative":{"exercise_price":10.875,"expiration_date":"2007-01-20","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000731766-03-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000031/edgardoc.xml","form_type":"4"}},{"id":297275,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-12-22T16:51:28.000Z","date":"2003-12-19","kind":"other","acquired":false,"shares":18760,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Because this is the disposition of a derivative security, sale price does not apply."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in four equal annual installments beginning December 1, 2000."}],"balance_after":0,"derivative":{"exercise_price":10.0313,"expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0000731766-03-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000031/edgardoc.xml","form_type":"4"}},{"id":297274,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-12-22T16:51:28.000Z","date":"2003-12-19","kind":"sale","acquired":false,"shares":63760,"price":55.91,"value":3564821.6,"ownership":{"direct":true},"balance_after":10180,"source":{"system":"sec-edgar","filing":"0000731766-03-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000031/edgardoc.xml","form_type":"4"}},{"id":297273,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-12-22T16:51:28.000Z","date":"2003-12-19","kind":"other","acquired":true,"shares":18760,"price":10.0313,"value":188187.188,"ownership":{"direct":true},"balance_after":73940,"source":{"system":"sec-edgar","filing":"0000731766-03-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000031/edgardoc.xml","form_type":"4"}},{"id":297272,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-12-22T16:51:28.000Z","date":"2003-12-19","kind":"other","acquired":true,"shares":45000,"price":10.875,"value":489375.0,"ownership":{"direct":true},"balance_after":55180,"source":{"system":"sec-edgar","filing":"0000731766-03-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000031/edgardoc.xml","form_type":"4"}},{"id":297800,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2003-12-02T19:53:19.000Z","date":"2003-11-28","kind":"other","acquired":true,"shares":50000,"price":53.9,"value":2695000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable in four equal annual installments beginning 11/28/04."}],"balance_after":50000,"derivative":{"exercise_price":53.9,"exercise_date":"2004-11-28","expiration_date":"2013-11-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000731766-03-000012","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000012/edgardoc.xml","form_type":"4"}},{"id":298323,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-11-17T14:49:42.000Z","date":"2003-11-13","kind":"gift","acquired":false,"shares":215,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10180,"source":{"system":"sec-edgar","filing":"0000731766-03-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000073176603000004/edgardoc.xml","form_type":"4"}},{"id":299585,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-10-10T20:10:53.000Z","date":"2003-10-09","kind":"gift","acquired":false,"shares":500,"price":51.58,"value":25790.0,"ownership":{"direct":true},"balance_after":9826,"source":{"system":"sec-edgar","filing":"0001179983-03-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000117998303000002/edgardoc.xml","form_type":"4"}},{"id":299584,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-10-10T20:10:53.000Z","date":"2003-10-09","kind":"gift","acquired":false,"shares":100,"price":51.58,"value":5158.0,"ownership":{"direct":true},"balance_after":10326,"source":{"system":"sec-edgar","filing":"0001179983-03-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000117998303000002/edgardoc.xml","form_type":"4"}},{"id":299583,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-10-10T20:10:53.000Z","date":"2003-10-09","kind":"gift","acquired":false,"shares":500,"price":51.58,"value":25790.0,"ownership":{"direct":true},"balance_after":10426,"source":{"system":"sec-edgar","filing":"0001179983-03-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000117998303000002/edgardoc.xml","form_type":"4"}},{"id":302237,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-08-11T16:48:10.000Z","date":"2003-08-07","kind":"gift","acquired":false,"shares":50,"price":49.97,"value":2498.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Indirect holdings = 1,284 shares held by 401(k) account"}],"balance_after":11495,"source":{"system":"sec-edgar","filing":"0001209191-03-016393","document":"bmn78958_bmn1leq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103016393/bmn78958_bmn1leq.xml","form_type":"4"}},{"id":304264,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-07-25T19:50:37.000Z","date":"2003-07-24","kind":"gift","acquired":false,"shares":180,"price":53.25,"value":9585.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"1,284 shares held indirectly by 401(k) account"}],"balance_after":10976,"source":{"system":"sec-edgar","filing":"0001209191-03-013677","document":"bmn78088_bmn7leq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103013677/bmn78088_bmn7leq.xml","form_type":"4"}},{"id":305253,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option","published_at":"2003-05-20T14:01:37.000Z","date":"2003-05-16","kind":"exercise","acquired":false,"shares":9380,"price":188186.25,"value":1765187025.0,"ownership":{"direct":true},"balance_after":9380,"derivative":{"exercise_price":20.0625,"exercise_date":"2003-05-16","expiration_date":"2009-10-13","underlying":"Common Stock","underlying_shares":9380},"source":{"system":"sec-edgar","filing":"0001209191-03-004913","document":"bmn76918_bmn9-leq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004913/bmn76918_bmn9-leq.xml","form_type":"4"}},{"id":305252,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Non-Qualified Stock Option","published_at":"2003-05-20T14:01:37.000Z","date":"2003-05-16","kind":"exercise","acquired":false,"shares":20252,"price":436051.89,"value":8830922876.28,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.5313,"exercise_date":"2003-05-16","expiration_date":"2007-10-27","underlying":"Common Stock","underlying_shares":20252},"source":{"system":"sec-edgar","filing":"0001209191-03-004913","document":"bmn76918_bmn9-leq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004913/bmn76918_bmn9-leq.xml","form_type":"4"}},{"id":305251,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-05-20T14:01:37.000Z","date":"2003-05-16","kind":"sale","acquired":false,"shares":29632,"price":95.3,"value":2823929.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"650 shares held indirectly by 401(k) account"}],"balance_after":5578,"source":{"system":"sec-edgar","filing":"0001209191-03-004913","document":"bmn76918_bmn9-leq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004913/bmn76918_bmn9-leq.xml","form_type":"4"}},{"id":305250,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-05-20T14:01:37.000Z","date":"2003-05-16","kind":"exercise","acquired":true,"shares":9380,"price":20.0625,"value":188186.25,"ownership":{"direct":true},"balance_after":35210,"source":{"system":"sec-edgar","filing":"0001209191-03-004913","document":"bmn76918_bmn9-leq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004913/bmn76918_bmn9-leq.xml","form_type":"4"}},{"id":305249,"issuer":{"id":2809,"kind":"organization","name":"UNITEDHEALTH GROUP INC","symbol":"UNH"},"owners":[{"id":13537,"kind":"person","name":"QUAM LOIS E","position":1,"cik":"0001179983","reported_name":"QUAM LOIS E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Ovations, Inc."}}],"security":"Common Stock","published_at":"2003-05-20T14:01:37.000Z","date":"2003-05-16","kind":"exercise","acquired":true,"shares":20252,"price":21.5313,"value":436051.8876,"ownership":{"direct":true},"balance_after":25830,"source":{"system":"sec-edgar","filing":"0001209191-03-004913","document":"bmn76918_bmn9-leq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/731766/000120919103004913/bmn76918_bmn9-leq.xml","form_type":"4"}}]}